These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2505715)

  • 1. [Perindopril: first-line treatment of arterial hypertension].
    Zanchetti A; Desche P
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():63-72. PubMed ID: 2505715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perindopril: first-line treatment for hypertension.
    Zanchetti A; Desche P
    Clin Exp Hypertens A; 1989; 11 Suppl 2():555-73. PubMed ID: 2691129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
    Thurston H; Desche P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S45-9. PubMed ID: 1725202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
    Letellier P; Overlack A; Agnes E; Desche P
    J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril versus perindopril: a double blind study in essential hypertension.
    Lees KR; Reid JL; Scott MG; Hosie J; Herpin D; Santoni JP
    J Hum Hypertens; 1989 Feb; 3(1):17-22. PubMed ID: 2657055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
    Thurston H
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():67-71. PubMed ID: 1395119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P; Dallocchio M; Gourgon R
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of mild and moderate hypertension with the use of captopril alone or combined with hydrochlorothiazide. A multicenter study].
    Nascimento LO; Lion R; Lion MF; Pesquisadores E
    Arq Bras Cardiol; 1989 Sep; 53(3):177-83. PubMed ID: 2698133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive action, clinical and biological acceptability of perindopril: main results in 23,460 patients with mild to moderate hypertension treated for 6 months in general practice].
    Fressinaud P; Berrut G; Gallois H
    Ann Cardiol Angeiol (Paris); 1993 Jan; 42(1):51-9. PubMed ID: 8480986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and acceptability of perindopril in essential hypertension.
    Sukonthasarn A; Ratanaprakarn R; Koanantakul B; Ngam-Ukos P
    J Med Assoc Thai; 1994 Jun; 77(6):281-7. PubMed ID: 7869013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical review of perindopril in the treatment of hypertension.
    Lerebours G; Antony I
    Can J Cardiol; 1994 Nov; 10 Suppl D():3D-7D. PubMed ID: 7954037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once daily perindopril versus slow release diltiazem in the treatment of mild to moderate essential hypertension. Canadian Study Group on Perindopril.
    Can J Cardiol; 1994 Nov; 10 Suppl D():8D-12D. PubMed ID: 7954041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in the elderly: a study of a combination of atenolol, hydrochlorothiazide and amiloride hydrochloride.
    Duckett GK; Cheadle B
    Br J Clin Pract; 1990 Sep; 44(9):354-8. PubMed ID: 2223528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo controlled double-blind randomised cross-over trial of atenolol, hydrochlorothiazide and amiloride, and the combination (Kalten) in patients over 60 years of age.
    Jackson G; Rowland M; Adam G; MacFarlane E; Jackson PG
    Br J Clin Pract; 1986 Jun; 40(6):230-4. PubMed ID: 3527246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.